| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $342K | -47.7% |
| Cost of Revenue | $70K | -42.1% |
| R&D Expense | $20.1M | -24.7% |
| SG&A Expense | $13.3M | -7.7% |
| Operating Income | -$33.1M | +18.4% |
| Pre-tax Income | -$39.4M | +20.4% |
| Income Tax | $0 | — |
| Net Income | -$39.4M | +20.4% |
| EPS (Basic) | -$5.67 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.2M | -57.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $64K | -55.2% |
| Inventory | $68K | +83.8% |
| Current Assets | $16.2M | -58.4% |
| Total Assets | $27.3M | -47.8% |
| Current Liabilities | $10.3M | -59.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | +29.3% |
| Capital Expenditures | $15K | -95.5% |
| Investing Cash Flow | $6.3M | +521.3% |
| Financing Cash Flow | -$1.5M | -103.6% |
| Free Cash Flow | -$21.3M | +30.0% |
| -1106.4% |
| Total Liabilities |
| $36.2M |
| -7.1% |
| Stockholders' Equity | -$8.9M | -166.1% |